Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EutR is a specialized transcriptional activator found in several enteric pathogens, including Salmonella typhimurium and various strains of Escherichia coli such as EHEC and UPEC. Its primary biological role is to regulate the ethanolamine utilization (eut) operon, which allows bacteria to metabolize ethanolamine—a common byproduct of host cell membrane turnover—as a source of carbon, nitrogen, and energy. This metabolic capability provides a significant fitness advantage during colonization of the host gastrointestinal and urinary tracts. Beyond its metabolic function, EutR serves as a critical sensor of the host environment, linking nutrient availability to the expression of virulence factors. In pathogens like EHEC, EutR directly activates the transcription of genes within the locus of enterocyte effacement (LEE), which are essential for the formation of attaching and effacing lesions. Because EutR is central to both bacterial survival and pathogenesis in the host, it is considered a promising target for the development of anti-virulence drugs. Such therapeutics aim to reduce the severity of infection and bacterial load without imposing the strong selective pressure for resistance typically seen with traditional antibiotics.
EutR acts as a ligand-dependent transcriptional activator that binds to ethanolamine and its essential cofactor adenosylcobalamin (Vitamin B12). Upon binding these effectors, EutR undergoes a conformational change that enables it to bind to the promoter regions of the ethanolamine utilization (eut) operon and other virulence-related genes (such as the LEE in EHEC or SPI-2 in Salmonella), thereby initiating their transcription and allowing the bacteria to adapt to the host environment.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HTH-type DNA-binding transcriptional activator EutR (EutR).